Princess Marina Hospital
Gaborone, Botswana
NCT Number: NCT06372093
The general objective of this study is to evaluate the accuracy of a novel smartphone application for jaundice screening (Picterus Jaundice Pro) in a population with high melanin content in the skin.
The specific objectives for this study are:
i. To assess the correlation between bilirubin level measurements obtained by Picterus Jaundice Pro with Total Serum Bilirubin (TSB), and TcB, in newborns with high melanin content in the skin.
ii. To determine the accuracy of Picterus Jaundice Pro in newborns with high melanin content in the skin.
Looking for future studies?
Notify Me1 day–14 day
All sexes
Interventional
Not applicable
Gaborone, Botswana
The goal for this project is to demonstrate that the Picterus Jaundice Pro screening method can be used to identify children with severe neonatal jaundice independent of skin color. Thus, providing a cheaper, patient-friendly, and more readily available method of neonatal jaundice detection. The long-term goal is that with the implementation of the app, the identification of newborns with severe jaundice will be improved and, thus, referred at an earlier stage for diagnostics and treatment.
The study will be a cross-sectional study with quantitative methods of data collection.
The study population will comprise 150 newborns from the Neonatal Unit and the maternity ward at Princess Marina Hospital.
Parents to newborns with and without signs of jaundice will be asked to participate.
Following informed consent, background data such as birth weight, age on examination, gestational age, and type of feeding will be obtained. Gestational age will be based on ultrasound determination and the last normal menstruation period (LNMP). The skin type of the infant will be classified according to the newborn Neomar's scale score.
Transcutaneous bilirubin measurements will be performed over the sternum of the infant. A Dräger Jaundice Meter JM-105 will be used in this study. Skin reflectance will be measured using a portable Konica Minolta spectrophotometer CM-700d.
A validated smartphone with Picterus Jaundice Pro will be used to collect digital images of skin of the infant chest together with the Picterus calibration card. After all the images are obtained, a unique ID will be displayed on the smartphone. This ID will be recorded on the case report forms and later used to pair clinical data and digital images.
A blood sample to determine TSB will be obtained within 60 minutes of obtaining the images and processed at the Department of clinical biochemistry in the hospital laboratory.
After completion of the study the bilirubin measurement from Picterus Jaundice Pro will be determined and compared to the TSB and TCB measurements using the Pearson correlation coefficient. Sub-analysis for the different skin colors will be performed. Systematic over- or under-estimation of bilirubin levels will be evaluated using Bland-Altman plots. Sensitivity and specificity analysis will be calculated for different cut-off values (ROC analysis).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Picterus Jaundice Pro is a smartphone based screening tool for neonatal jaundice that takes images of the skin of the newborn chest where the Picterus Calibration Card is placed.
Other names: Picterus JP
Time frame: 1 year
Evaluate of smartphone-based screening tool (Picterus JP) for neonatal jaundice in newborns with high melanin content.
Time frame: 1-2 hours
Correlate estimates of bilirubin levels obtained by Picterus JP with TSB and TcB in newborns with high melanin content in the skin.
Time frame: 1 year
Determine the sensitivity and specificity of Picterus JP to screen for jaundice in newborns with high melanin content in the skin
Picterus AS
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06687746
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Hodal, India
View Trial DetailsNCT03741803
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Houston, Texas, United States
View Trial DetailsNCT07388732
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyper Bilirubinemia
Kütahya, Province, Turkey (Türkiye)
View Trial DetailsNCT03805165
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Guangzhou, Guangdong, China
View Trial Details